Results 151 to 160 of about 769,984 (331)

Progressive Systemic Sclerosis- from the molecular background to innovative therapies [PDF]

, 2010
Péter Szodoray
openalex   +1 more source

Retinoma: An overview

Pediatric Investigation, EarlyView.
Retinoma, a benign tumor caused by biallelic retinoblastoma gene (RB1) inactivation, offers key insights into retinoblastoma development and oncogenesis. This review explores its molecular genetics, clinical features, diagnosis, management, and potential implications for advancing the prevention and treatment of retinoblastoma.
Panagiotis Toumasis, Ashwin Mallipatna, Timothy W. Corson, Helen Dimaras   +3 more
wiley   +1 more source

Gadolinium‐based contrast agent exposures and physical and cognitive disability in multiple sclerosis

Journal of Neuroimaging, Volume 33, Issue 1, Page 85-93, January/February 2023., 2023
Abstract Background and Purpose The clinical correlation of gadolinium‐based contrast agents (GBCAs) has not been well studied in multiple sclerosis (MS). We investigated the extent to which the number of GBCA administrations relates to self‐reported disability and performance measures. Methods A cohort of MS patients was analyzed in this retrospective
Kunio Nakamura, Marisa P. McGinley, Stephen E. Jones, Mark J. Lowe, Jeffrey A. Cohen, Paul M. Ruggieri, Daniel Ontaneda   +6 more
wiley   +1 more source

Rapid Progressive Systemic Sclerosis Following mRNA COVID-19 Vaccination

, 2023
Caley L, Flores P, Gonçalves AM, Real A, Nepomuceno J.   +4 more
europepmc   +1 more source

A reaction-diffusion model for relapsing-remitting multiple sclerosis with a treatment term [PDF]

arXiv
We present a mathematical study for the development of multiple sclerosis based on a reaction-diffusion system. The model describes interactions among different populations of human cells, motion of immune cells stimulated by cytokines, consumption of myelin sheath due to anomalously activated lymphocytes and its restoration by oligodendrocytes ...
arxiv  

Proteomic Insight Into Alzheimer's Disease Pathogenesis Pathways

PROTEOMICS, EarlyView.
ABSTRACT Alzheimer's disease (AD) is a leading cause of dementia, but the pathogenesis mechanism is still elusive. Advances in proteomics have uncovered key molecular mechanisms underlying AD, revealing a complex network of dysregulated pathways, including amyloid metabolism, tau pathology, apolipoprotein E (APOE), protein degradation ...
Taekyung Ryu, Kyungdo Kim, Nicholas Asiimwe, Chan Hyun Na   +3 more
wiley   +1 more source

Complete Atrioventricular Block and Cardiopulmonary Involvement in Rapidly Progressive Systemic Sclerosis

, 2021
Eduarda Cal Viegas, Diane Xavier de Ávila, Eduardo Nani Silva, Luís Otávio Mocarzel, Ronaldo Altenburg Gismondi   +4 more
openalex   +2 more sources

Prevalence of function‐limiting late effects in survivors of head and neck cancer

PM&R, EarlyView.
Abstract Background Survivors of head and neck cancer (HNC) are commonly affected by multiple complex and interrelated long‐term and late effects that can adversely affect their function and quality of life. Objective To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality ...
Yu Hui Won, Michael D. Stubblefield
wiley   +1 more source

Endothelial cell renewal in skin of patients with progressive systemic sclerosis (PSS): an in vitro autoradiographic study

, 1982
Suzanne Kazandjian, J N Fiessinger, JP Camilleri, JP. Dadoune, E. Housset   +4 more
openalex   +2 more sources

Colonic telangiectasias in progressive systemic sclerosis [PDF]

Endoscopy, 2012
Jharap, B., Koudstaal, L.G., Neefjes-Borst, E.A., van Weyenberg, S.J.B.   +3 more
openaire   +4 more sources